 |
||||||||
|
Orchid Chemicals & Pharmaceuticals Ltd |
||||||||
|
Audited Financial Results for the year ended
March 31, 2004
|
||||||||
|
(Rs.Lakhs)
|
||||||||
| Sl No |
Particulars
|
Nine months ended
31-Dec-03 (unaudited) |
Three Months ended
31-Mar-04 (unaudited) |
Three
Months ended
31-Mar-03 (unaudited)
|
Year ended
31-Mar-04 (Audited)
|
Year ended
31-Mar-03 (Audited)
|
Consolidated Accounts
31-Mar-04 (Audited)
|
Consolidated Accounts
31-Mar-03 (Audited)
|
|
1
|
Sales and Operating Income |
50565.80
|
20775.17
|
19496.25
|
71340.98
|
54141.43 |
69931.94
|
54097.38
|
|
2
|
Other Income |
103.71
|
19.41
|
71.84
|
123.12
|
111.38
|
124.61
|
111.56
|
|
3
|
Total Expenditure |
39768.85
|
16646.16
|
15619.38
|
56415.00
|
43289.70
|
55540.89
|
43364.24
|
|
a) Decrease/(Increase) in Stock in trade |
(3586.38)
|
(801.37)
|
(2278.08)
|
(4387.75)
|
(4702.99)
|
(5072.55)
|
(4636.38)
|
|
| b) Consumption of raw materials |
28265.87
|
11089.58
|
12347.12
|
39355.45
|
31910.92
|
38993.61
|
31910.91
|
|
| c) Staff Cost |
3362.97
|
1478.63
|
1231.39
|
4841.60
|
3403.16
|
4841.60
|
3403.16
|
|
| d) Other Expenditure |
11726.39
|
4879.32
|
4318.95
|
16605.70
|
12678.61
|
16778.23
|
12686.55
|
|
|
4
|
Profit before Interest, Depreciation & Tax
(1+2-3)
|
10900.66
|
4148.42
|
3948.71
|
15049.10
|
10963.11
|
14515.66
|
10844.70
|
|
5
|
Interest and Finance Charges |
4411.66
|
1655.42
|
1402.89
|
6067.08
|
4207.69
|
6093.77
|
4215.49
|
|
6
|
Depreciation |
4018.42
|
1665.81
|
1152.60
|
5684.23
|
4030.71
|
5724.52
|
4031.34
|
|
7
|
Profit before tax |
2470.58
|
827.19
|
1393.22
|
3297.79
|
2724.71
|
2697.37
|
2597.87
|
|
8
|
Provision for Taxation |
|
|
|||||
| - Current Tax |
143.10
|
51.90
|
195.00
|
195.00
|
||||
| - Deferred Tax |
390.82
|
770.65
|
770.65
|
|||||
|
9
|
Net Profit (7-8) |
2327.48
|
775.31
|
1002.40
|
3102.79
|
1954.06
|
2502.37
|
1827.22
|
|
10
|
Paid- up Equity Share Capital (Face value of Rs. 10 each) |
3238.19
|
3238.19
|
3238.19
|
3238.19
|
3238.19
|
3238.19
|
3238.19
|
|
11
|
Reserves excluding Revaluation Reserves |
|
|
38630.88
|
36990.13
|
37875.42
|
36775.83
|
|
|
12
|
Basic Earnings per Share (Rs.) |
7.19*
|
2.39
|
3.10
|
9.58
|
6.61
|
7.73
|
6.18
|
| 13 |
Aggregate of Non-Promoter Shareholding |
27704462 |
27640677 |
|||||
|
85.56
|
85.36
|
|||||||
| *EPS is for the period (not annualised) after providing for taxes | ||||||||
| SEGMENT WISE REVENUE, RESULTS AND CAPITAL EMPLOYED | ||||||||||
|
(Rs.Lakhs)
|
||||||||||
|
Particulars
|
Nine months ended
31-Dec-03 |
Three months ended
31-Mar-04 |
Three Months ended
31-Mar-03
|
Year ended
31-Mar-04
|
Year ended
31-Mar-03
|
Consolidated Accounts
31-Mar-04
|
Consolidated Accounts
31-Mar-03
|
|||
| 1. Segment Revenue |
|
|
|
|||||||
| a. Bulk |
44198.71
|
18256.52
|
18172.00
|
62455.23
|
50066.25
|
62786.85
|
49945.62
|
|||
| b. Formulations |
7915.93
|
2525.20
|
2191.72
|
10441.13
|
6346.07
|
10441.13
|
6422.65
|
|||
| Total |
52114.64
|
20781.72
|
20363.72
|
72896.36
|
56412.32
|
73227.98
|
56368.27
|
|||
| Less: Inter segment revenue |
1548.84
|
6.55
|
867.47
|
1555.38
|
2270.89
|
3296.04
|
2270.89
|
|||
| Net Sales / Income from Operations |
50565.80
|
20775.17
|
19496.25
|
71340.98
|
54141.43
|
69931.94
|
54097.38
|
|||
|
|
|
|
|
|||||||
| 2. Segment Results: Profit/(Loss) before interest & Tax |
|
|
|
|
||||||
| a. Bulk |
6724.50
|
2822.22
|
3473.43
|
9546.72
|
7315.15
|
8939.71
|
7187.88
|
|||
| b. Formulations |
261.45
|
(309.01)
|
(707.43)
|
(128.57)
|
(452.40)
|
(128.57)
|
(444.17)
|
|||
| Total |
6985.95
|
2432.21
|
2766.00
|
9418.15
|
6862.75
|
8811.14
|
6743.71
|
|||
|
|
|
|
|
|||||||
| Less: i) Interest (Net) |
4411.66
|
1655.42
|
1402.89
|
6067.08
|
4207.69
|
6093.77
|
4215.49
|
|||
| ii) Other unallocable expenditure net off unallocable income |
103.71
|
(50.40)
|
(30.11)
|
53.28
|
(69.65)
|
20.00
|
(69.65)
|
|||
| Total Profit Before Tax |
2470.58
|
827.19
|
1393.22
|
3297.79
|
2724.71
|
2697.37
|
2597.87
|
|||
|
|
|
|
|
|||||||
| 3. Capital Employed |
|
|
|
|
||||||
| a. Bulk |
120560.36
|
106458.81
|
98935.81
|
106458.81
|
98935.81
|
109160.74
|
98808.93
|
|||
| b. Formulations |
9611.45
|
15737.57
|
9350.00
|
15737.57
|
9350.00
|
15737.57
|
9262.57
|
|||
| Total |
130171.81
|
122196.38
|
108285.81
|
122196.38
|
108285.81
|
124898.31
|
108071.50
|
|||
| * EPS is for the period (not annualised) after providing fo deferred tax. | ||||||||||
| 1 | The above financial results were adopted by the Board of Directors at its meeting held on Sunday, April 25, 2004. | |||||||||
| 2 | The Board of Directors have recommended a dividend of 40% (Rs 4 /-per share) on the equity share of Rs 10 each. | |||||||||
| 3 | The Allotment Committee of the Board at its meeting held on April 23, 2004 allotted 20,00,000 Warrants on private placement basis to promoters / promoter group, at a price of Rs. 212.18 each, convertible into equity shares of Rs. 10/- each, within eighteen months from the date of allotment. | |||||||||
| 4 | The Compensation Committee of the Board in its meeting held on January 20, 2004 approved the issue of 307,925 stock options to employees. The stock options are convertible into equity shares of Rs. 10/- each, at a price of Rs. 252/- per share, being the closing price of shares of Orchid at the National Stock Exchange of India Limited on the date of grant of options. | |||||||||
| 5 | The Company's consolidated financial statements include the financial statement of the Company's subsidiaries in UK and Brazil as well as the Company's Joint Ventures in China, UK and USA. The Consolidated financial statements of the Company have been prepared in accordance with Accounting Standard 27 / 23 issued by the Institute of Chartered Accountants of India. | |||||||||
| 6 | The Company received 12 complaints during the quarter ended March 31, 2004 from the shareholders. All the complaints have been resolved and no complaints were pending as on March 31, 2004. | |||||||||
| 7 | Previous period figures have been regrouped wherever necessary. | |||||||||
|
||||||||||